All Stories

  1. Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trial

    Article • PLOS One, April 2026, PLOS

    Asma Aziz

  2. Strengthening community engagement capacity for vaccine trial readiness in West Africa: A platform approach anchored in Lassa fever preparedness

    Article • Journal of Interventional Epidemiology and Public Health, August 2025, African Field Epidemiology Network

    Asma Aziz

  3. Epidemiological and Clinical Features of Enterotoxigenic Escherichia coli (ETEC) Diarrhea in an Urban Slum in Dhaka, Bangladesh

    Article • Open Forum Infectious Diseases, June 2025, Oxford University Press (OUP)

    Asma Aziz

  4. Cellular and Humoral Immune Profiles After Hepatitis E Vaccination and Infection

    Article • Viruses, June 2025, MDPI AG

    Asma Aziz

  5. Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control Study

    Article • Clinical Infectious Diseases, June 2025, Oxford University Press (OUP)

    Asma Aziz

  6. Raising the case of hepatitis E: Report from the 2nd international HEV symposium

    Article • Vaccine, December 2024, Elsevier

    Asma Aziz

  7. Hepatitis E vaccine and fetal loss: the potential pathophysiological basis – Authors' reply

    Article • The Lancet Global Health, November 2024, Elsevier

    Asma Aziz

  8. Using Dried Blood Spots to Quantitatively Detect Anti–SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study

    Article • American Journal of Tropical Medicine and Hygiene, August 2024, American Society of Tropical Medicine and Hygiene

    Asma Aziz

  9. Spatial and temporal clustering of typhoid fever in an urban slum of Dhaka City: Implications for targeted typhoid vaccination

    Article • PLoS Neglected Tropical Diseases, June 2024, PLOS

    Asma Aziz

  10. Do Oral Cholera Vaccine and Water, Sanitation, and Hygiene Combine to Provide Greater Protection Against Cholera? Results From a Cluster-Randomized Trial of Oral Cholera Vaccine in Kolkata, India

    Article • Open Forum Infectious Diseases, January 2024, Oxford University Press (OUP)

    Asma Aziz

  11. Better Existing Water, Sanitation, and Hygiene Can Reduce the Risk of Cholera in an Endemic Setting: Results From a Prospective Cohort Study From Kolkata, India

    Article • Open Forum Infectious Diseases, November 2023, Oxford University Press (OUP)

    Asma Aziz

  12. Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial

    Article • Vaccine, January 2023, Elsevier

    Asma Aziz

  13. Hepatitis E Virus (HEV) Synopsis: General Aspects and Focus on Bangladesh

    Article • Viruses, December 2022, MDPI AG

    Asma Aziz

  14. Cost of oral cholera vaccine delivery in a mass immunization program for children in urban Bangladesh

    Article • Vaccine X, December 2022, Elsevier

    Asma Aziz

  15. Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines

    Article • Clinical Infectious Diseases, November 2022, Oxford University Press (OUP)

    Asma Aziz

  16. Stability and Feasibility of Dried Blood Spots for Hepatitis E Virus Serology in a Rural Setting

    Article • Viruses, November 2022, MDPI AG

    Asma Aziz

  17. Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial

    Article • The Lancet Infectious Diseases, November 2022, Elsevier

    Asma Aziz

  18. Are better existing WASH practices in urban slums associated with a lower long-term risk of severe cholera? A prospective cohort study with 4 years of follow-up in Mirpur, Bangladesh

    Article • BMJ Open, September 2022, BMJ

    Asma Aziz

  19. Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines

    Article • August 2022, openRxiv

    Asma Aziz

  20. One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh

    Article • The Journal of Infectious Diseases, May 2022, Oxford University Press (OUP)

    Asma Aziz

  21. Prevention of Typhoid by Vi Conjugate Vaccine and Achievable Improvements in Household Water, Sanitation, and Hygiene: Evidence From a Cluster-Randomized Trial in Dhaka, Bangladesh

    Article • Clinical Infectious Diseases, April 2022, Oxford University Press (OUP)

    Asma Aziz

  22. Prevention of Typhoid Fever by Existing Improvements in Household Water, Sanitation, and Hygiene, and the Use of the Vi Polysaccharide Typhoid Vaccine in Poor Urban Slums: Results from a Cluster-Randomized Trial

    Article • American Journal of Tropical Medicine and Hygiene, April 2022, American Society of Tropical Medicine and Hygiene

    Asma Aziz

  23. Perceptions about Telemedicine among Populations with Chronic Diseases amid COVID-19: Data from a Cross-Sectional Survey

    Article • International Journal of Environmental Research and Public Health, April 2022, MDPI AG

    Asma Aziz

  24. Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial

    Article • Vaccine X, April 2022, Elsevier

    Asma Aziz

  25. Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries

    Article • EClinicalMedicine, January 2022, Elsevier

    Asma Aziz

  26. Multiscale model for forecasting Sabin 2 vaccine virus household and community transmission

    Article • PLoS Computational Biology, December 2021, PLOS

    Asma Aziz

  27. Rotavirus Vaccine Trials in International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and Future Use of the Vaccine in Bangladesh

    Article • The Journal of Infectious Diseases, September 2021, Oxford University Press (OUP)

    Asma Aziz

  28. Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial

    Article • Vaccine, September 2021, Elsevier

    Asma Aziz

  29. Re-evaluation of population-level protection conferred by a rotavirus vaccine using the ‘fried-egg’ approach in a rural setting in Bangladesh

    Article • Vaccine, September 2021, Elsevier

    Asma Aziz

  30. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

    Article • International Journal of Infectious Diseases, February 2021, Elsevier

    Asma Aziz

  31. Integrated control of COVID-19 in resource-poor countries

    Article • International Journal of Infectious Diseases, December 2020, Elsevier

    Asma Aziz

  32. Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials?

    Article • Biosafety and Health, September 2020, Elsevier

    Asma Aziz

  33. Community structure mediates Sabin 2 polio vaccine virus transmission

    Article • July 2020, openRxiv

    Asma Aziz

  34. Impact of vaccination on the risk factors for acute rotavirus diarrhea: An analysis of the data of a cluster randomized trial conducted in a rural area of Bangladesh

    Article • Vaccine, February 2020, Elsevier

    Asma Aziz

  35. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh

    Article • BMJ Open, January 2020, BMJ

    Asma Aziz

  36. A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants

    Article • Human Vaccines & Immunotherapeutics, October 2019, Taylor & Francis

    Asma Aziz

  37. Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

    Article • The Lancet Child & Adolescent Health, May 2018, Elsevier

    Dr Javier Diez-Domingo, Asma Aziz

  38. Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase ...

    Article • Vaccine, January 2018, Elsevier

    Asma Aziz

  39. AN EXPLORATION OF THE FEASIBILITY OF INTRODUCING ROTA VACCINE INTO THE ROUTINE EPI SCHEDULE OF BANGLADESH

    Article • Public Health of Indonesia, June 2017, Indonesian Public Health Association

    Asma Aziz